Marta Toledano-Fonseca

7PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 03, 2026
NR3C1, LAX1, and RCAN3 as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer.

Pablo Cano-Ramírez, Marta Toledano-Fonseca, María Teresa Cano-Osuna

|Aug 01, 2025
Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patients.

Marta Toledano-Fonseca, María Teresa Cano-Osuna, Elena Élez

|Jun 10, 2025
Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement.

Carmen Navarrete-Sirvent, Ana Mantrana, Aurora Rivas-Crespo

|Jul 09, 2022
Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab.

M José Ortiz-Morales, Marta Toledano-Fonseca, Rafael Mena-Osuna

|Apr 03, 2021
The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer.

Marta Toledano-Fonseca, M Teresa Cano, Elizabeth Inga

|Jul 08, 2020
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer.

Marta Toledano-Fonseca, M Teresa Cano, Elizabeth Inga

Pageof 2

Frequent Collaborators

6 joint publications

Antonio Rodríguez-Ariza

4 joint publications

Silvia Guil-Luna

3 joint publications

Enrique Aranda

2 joint publications

Rafael Mena-Osuna